Last reviewed: June 28, 2026
Last updated: June 28, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Ozempic is approved by the FDA for managing type 2 diabetes, not weight loss—that indication belongs to Wegovy, a higher-dose formulation of the same active ingredient, semaglutide. The confusion between these two products stems from their identical mechanism but different regulatory pathways. PlexusDx provides access to compounded semaglutide injections without the brand-name markup, making GLP-1 therapy more affordable for eligible patients across all 50 states.
Understanding Ozempic's FDA Approval Status
Ozempic received FDA clearance on September 17, 2017, specifically for blood sugar management in adults with type 2 diabetes. The approval was based on clinical trials demonstrating reduction in hemoglobin A1C levels and cardiovascular benefits in high-risk patients. However, this diabetes indication does not extend to weight loss as a primary goal, which is a critical distinction many patients misunderstand when researching GLP-1 medications.
Wegovy, the weight loss version of semaglutide, entered the market in June 2021 after the FDA approved it for chronic weight management in adults with obesity or overweight status. Wegovy uses higher maintenance doses than Ozempic and follows a different dosing schedule optimized for metabolic weight loss rather than glucose control. Both medications contain identical semaglutide but target different patient populations and clinical outcomes under separate brand names.
How Semaglutide Works for Weight Loss and Blood Sugar
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone your body produces to regulate appetite and blood sugar. The medication slows gastric emptying, meaning food stays in your stomach longer, which triggers earlier satiety signals to your brain. This dual action—appetite suppression combined with improved insulin sensitivity—creates the metabolic foundation for sustainable weight reduction in eligible patients.
Clinical trials of Wegovy showed participants lost an average of 15% of body weight over 68 weeks, with some individuals achieving losses exceeding 20%. The weight loss effect persists only while taking the medication; discontinuing treatment typically results in gradual weight regain over months. PlexusDx compounded semaglutide injections provide the same active ingredient at a fraction of brand-name costs, starting at $149 per month across all three commitment tiers.
Compounded Semaglutide vs. Brand-Name Wegovy
Wegovy carries a list price around $900–$1,350 per month depending on dose, while PlexusDx's compounded semaglutide injections start at just $149 monthly. Both formulations contain the same active pharmaceutical ingredient and work through identical biological pathways in your body. The price difference reflects the elimination of brand marketing, clinical trial recoupment costs, and bulk manufacturing economies available through licensed 503A compounding pharmacies.
PlexusDx compounds semaglutide through partner pharmacies that hold proper 503A licenses and operate under strict federal and state quality standards. Your dose may need to increase over time for optimal results, but your price remains flat—no hidden tier jumps or dose-based surcharges. The medication is available to residents in all 50 states without insurance requirements, membership fees, or prior authorization delays typical of branded products.
Personalized Dosing and the Precision Peptide Genetic Test
Not all patients respond identically to semaglutide because genetic variations affect how your body processes GLP-1 signaling and metabolic hormones. PlexusDx's Precision Peptide Genetic Test identifies your unique peptide-pathway genetics by analyzing variants in four key genes: GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313. These insights map 14 distinct biological pathways and 49 peptides, providing your provider with 150+ data points to optimize your dose and protocol from month one.
The genetic test costs $99 as an add-on after your first month of treatment, allowing your clinician to understand whether you're a strong GLP-1 responder, GIPR-dominant candidate, or better suited for dual-compound protocols like GLP-Squared. This precision approach reduces trial-and-error dosing and accelerates your path to therapeutic response. Patients with genetic predispositions favoring faster results often reach their target dose more efficiently when guided by Precision Peptide testing.
Is Compounded Semaglutide Right for You?
You are a candidate for PlexusDx compounded semaglutide if you have a body mass index (BMI) of 30 or higher, or a BMI of 27+ with weight-related health conditions such as hypertension, type 2 diabetes, or sleep apnea. The medication requires a valid prescription from a licensed healthcare provider; PlexusDx's telehealth partners can evaluate your medical history, current medications, and contraindications during a secure virtual consultation. Common exclusions include a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 syndrome.
Starting your treatment is straightforward: schedule a telehealth appointment, receive your prescription within 24 hours if approved, and receive your first shipment within 3–5 business days. PlexusDx accepts HSA and FSA funds for all compounded medications, making therapy even more affordable for enrolled patients. Your monthly cost of $149 remains unchanged whether your provider titrates you to 0.5 mg, 1 mg, 2 mg, or the maximum therapeutic dose.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is Ozempic actually FDA-approved for weight loss?
No. Ozempic is FDA-approved only for type 2 diabetes management. Wegovy, the higher-dose formulation of semaglutide, is the FDA-approved weight loss medication. Both contain identical semaglutide but are marketed separately for different clinical indications and patient populations.
What does the clinical evidence say about semaglutide for weight loss?
Pivotal trials of Wegovy (semaglutide) showed average weight loss of 15% of body weight over 68 weeks, with some patients losing 20% or more. Weight loss is sustained only while taking the medication; discontinuation typically leads to gradual regain. PlexusDx compounded semaglutide contains the same active ingredient and produces equivalent results at a lower cost.
How much does PlexusDx compounded semaglutide cost compared to Wegovy?
PlexusDx semaglutide injections start at $149 per month, versus Wegovy's typical brand-name cost of $900–$1,350 monthly. Your dose may increase over time, but your price stays flat at $149—no hidden tier increases. HSA and FSA funds are accepted, and no insurance is required.
Are compounded medications as safe as FDA-approved brand-name drugs?
PlexusDx compounds semaglutide through licensed 503A compounding pharmacies that meet strict federal and state quality, sterility, and potency standards. While compounded medications are not FDA-approved in the traditional sense, they contain identical active pharmaceutical ingredients to their brand counterparts and are legally prescribed by licensed clinicians nationwide.
What is the Precision Peptide Genetic Test and how does it help with semaglutide?
The Precision Peptide Genetic Test ($99, available after your first treatment month) analyzes variants in GLP1R, GIPR, FTO, and MC4R genes to map your unique peptide-pathway biology. This helps your provider predict your individual response to semaglutide, optimize your starting dose, and determine if dual-compound protocols like GLP-Squared may accelerate your results.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Optimal Timing: When is the Best Time to Take Ozempic for Your Health Journey?
How Much Weight Do You Gain Back After Stopping Zepbound?